Silgan Holdings earnings beat by $0.06, revenue fell short of estimates

Silgan Holdings (SLGN) reported Q3 EPS of $1.31, beating estimates by $0.06, but revenue of $2.04B missed expectations of $2.1B. The stock is down 5.13% over 3 months and 0.86% over 12 months, with mixed EPS revisions. InvestingPro rates its financial health as 'good performance'.

Original reporting
Published Oct 29, 2026, 10:11 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 10:19 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$SLGN
Neutral
medium confidence
Mentioned
$SLGN
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$SLGNNeutralMed
01

Why it matters

EPS outperformance may support the stock, but the revenue shortfall can temper expectations for demand and near-term growth.

02

Market read

This is a straightforward earnings print with a beat on EPS and a miss on revenue, which typically drives short-term repricing.

03

What to watch

Without segment performance, guidance, or margin commentary, traders may be over-weighting the revenue miss relative to underlying profitability trends.

Relevance 8/10Novelty 6/10Timing: reported Q3 results, with market reaction likely around the earnings release window

Background

The piece summarizes Silgan Holdings’ Q3 earnings versus consensus and notes recent EPS estimate revisions.

Company-level read

Ticker impact

$SLGNNeutralMedium confidence
Context

Silgan Holdings reported Q3 EPS of $1.31, beating the $1.25 estimate, while revenue missed at $2.04B vs $2.1B consensus.

Expected impact

Shares may face limited upside or choppy trading as the market weighs the EPS beat against the revenue miss.

Evidence & confidence

The article provides the core earnings datapoints (EPS beat, revenue miss) but no guidance or margin detail, limiting conviction on direction beyond a mixed reaction.

Market effects

As a packaging/containers name, results can marginally influence sentiment toward consumer/industrial packaging demand, but the article lacks broader sector signals.

Primarily US-listed single-name impact; no cross-market macro catalyst is described.

Limited global spillover given the article is focused on a single company’s quarterly print.

Counterpoint

The EPS beat could indicate cost control or favorable mix, and the revenue miss may be temporary, supporting a rebound thesis if investors focus on earnings quality.

Key entities

  • Silgan Holdings

    NYSE-listed packaging company reporting Q3 EPS and revenue versus analyst consensus.

Related articles

$SLGNMedAI 8/10

What Silgan (SLGN) Said on Its Q3 Earnings Call

Silgan (SLGN) raised its full-year 2026 adjusted EPS outlook to $3.83-$3.93, up from $3.72 in 2025. Q4 adjusted EPS is projected at $0.76-$0.86. The company expects $450M in free cash flow for 2026. Silgan also discussed its planned acquisition of Trivium, expected to close in mid-2027, which will create two new packaging businesses.

$SLGNMed

Silgan Holdings Inc (SLGN) Q3 2026 Earnings Call Highlights: Record Adjusted EPS

Silgan Holdings (SLGN) reported Q3 2026 earnings with record adjusted EPS and raised guidance. Weak consumer demand impacted volumes, especially in food, beverage, and home care. Margins in dispensing and specialty closures declined for six quarters but are expected to stabilize in Q4. The Trivium acquisition will require investments and may pose execution risks. CEO Adam Greenlee highlighted growth in wet pet food, fragrance, and prescription pharma.

$SLGNHighAI 8/10

Silgan Q3 profit slips despite higher sales

Silgan reported a Q3 2026 net income decline to $105m ($0.99 per share) from $113.3m ($1.06 per share) year-over-year, despite a 2% sales increase to $2.04bn. EBIT fell to $191.7m. The company raised its 2026 adjusted earnings outlook to $3.83-$3.93 per share and announced a $3.4bn acquisition of Trivium Packaging.

$SLGNHighAI 8/10

Silgan Q3 Adjusted EPS Hits Record $1.31, Full-Year Guidance Midpoint Raised

Silgan Holdings (SLGN) reported Q3 2026 net sales of $2.04B and adjusted EPS of $1.31, up from $1.22 a year earlier. Full-year adjusted EPS guidance was raised to $3.83-$3.93. Net sales rose 2% YoY, while GAAP net income fell to $105M. The company expects 2026 free cash flow of $450M and capital expenditures of $310M. CEO Adam Greenlee highlighted the acquisition of Trivium as a transformative move.

$SLGNMedAI 8/10

SILGAN ANNOUNCES THIRD QUARTER 2026 RESULTS

SILGAN HOLDINGS INC (SLGN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Silgan Holdings Inc. Exhibit 99.1 SILGAN ANNOUNCES THIRD QUARTER 2026 RESULTS; RAISES FULL YEAR EARNINGS ESTIMATE MIDPOINT H ighlights • Announced transformative portfolio acceleration through the acquisition of Trivium • Achieved double digit growth in dispensing products for ph